Blue Owl Capital Holdings »

CID Holdco shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of CID Holdco (DAIC) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in CID Holdco

Tip: Access up to 7 years of quarterly data

All positions including CID Holdco held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CID Holdco by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $251k 557k 0.45

More positions owned by Blue Owl Capital Holdings

Engene Holdings (ENGN)
Nuveen Churchill Direct Lend Com Shs (NCDL)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Cullinan Oncology (CGEM)
Compass Therapeutics (CMPX)
Holley (HLLY)
Context Therapeutics (CNTX)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord
Civeo Corp Cda Com New (CVEO)
Sagimet Biosciences Com Ser A (SGMT)
Eyepoint Com New (EYPT)
Procore Technologies (PCOR)
Dell Technologies CL C (DELL)

View all positions for Blue Owl Capital Holdings

Top funds holding CID Holdco

Blue Owl Capital Holdings
Mutual Advisors
Moore Capital Management
Vanguard Group
Highbridge Capital Management
Geode Capital Management
Millennium Management
Periscope Capital
Arrien Investments
Atlas Merchant Capital
DecisionPoint Financial
Northern Trust
Scratch Capital
Legacy Wealth Managment
CacheTech

View all funds holding CID Holdco